anti ki67 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
anti ki67
Anti Ki67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1260 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+ki67/Ki-67+Mouse+mAb/pm41925955-76-51-58
Average 96 stars, based on 1260 article reviews
Anti Ki67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1260 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+ki67/Ki-67+Mouse+mAb/pm41925955-76-51-58
Average 96 stars, based on 1260 article reviews
anti ki67 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Staining:Article Title: Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy. Article Snippet: .. For CK7 and CK19 cytokeratin staining, simultaneous permeabilization and blocking were performed at room temperature using 0.3% Triton X-100 (Sigma–Aldrich) and 3% bovine serum albumin (BSA, Sigma-Aldrich) for 1.5 h. For Ki67 and EpCAM staining, samples were first permeabilized with 0.3% Triton X-100 for 30 min, followed by three 5-min PBS washes, and then blocked with 3% BSA for 1 h. The blocked ICC_3DP constructs were incubated overnight with primary antibodies diluted in antibody diluent (Invitrogen), including mouse anti-CK7 (1:200, Abcam), rabbit anti-CK19 (1:200, Abcam), Blocking Assay:Article Title: Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy. Article Snippet: .. For CK7 and CK19 cytokeratin staining, simultaneous permeabilization and blocking were performed at room temperature using 0.3% Triton X-100 (Sigma–Aldrich) and 3% bovine serum albumin (BSA, Sigma-Aldrich) for 1.5 h. For Ki67 and EpCAM staining, samples were first permeabilized with 0.3% Triton X-100 for 30 min, followed by three 5-min PBS washes, and then blocked with 3% BSA for 1 h. The blocked ICC_3DP constructs were incubated overnight with primary antibodies diluted in antibody diluent (Invitrogen), including mouse anti-CK7 (1:200, Abcam), rabbit anti-CK19 (1:200, Abcam), Immunocytochemistry:Article Title: Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy. Article Snippet: .. For CK7 and CK19 cytokeratin staining, simultaneous permeabilization and blocking were performed at room temperature using 0.3% Triton X-100 (Sigma–Aldrich) and 3% bovine serum albumin (BSA, Sigma-Aldrich) for 1.5 h. For Ki67 and EpCAM staining, samples were first permeabilized with 0.3% Triton X-100 for 30 min, followed by three 5-min PBS washes, and then blocked with 3% BSA for 1 h. The blocked ICC_3DP constructs were incubated overnight with primary antibodies diluted in antibody diluent (Invitrogen), including mouse anti-CK7 (1:200, Abcam), rabbit anti-CK19 (1:200, Abcam), Construct:Article Title: Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy. Article Snippet: .. For CK7 and CK19 cytokeratin staining, simultaneous permeabilization and blocking were performed at room temperature using 0.3% Triton X-100 (Sigma–Aldrich) and 3% bovine serum albumin (BSA, Sigma-Aldrich) for 1.5 h. For Ki67 and EpCAM staining, samples were first permeabilized with 0.3% Triton X-100 for 30 min, followed by three 5-min PBS washes, and then blocked with 3% BSA for 1 h. The blocked ICC_3DP constructs were incubated overnight with primary antibodies diluted in antibody diluent (Invitrogen), including mouse anti-CK7 (1:200, Abcam), rabbit anti-CK19 (1:200, Abcam), Incubation:Article Title: Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy. Article Snippet: .. For CK7 and CK19 cytokeratin staining, simultaneous permeabilization and blocking were performed at room temperature using 0.3% Triton X-100 (Sigma–Aldrich) and 3% bovine serum albumin (BSA, Sigma-Aldrich) for 1.5 h. For Ki67 and EpCAM staining, samples were first permeabilized with 0.3% Triton X-100 for 30 min, followed by three 5-min PBS washes, and then blocked with 3% BSA for 1 h. The blocked ICC_3DP constructs were incubated overnight with primary antibodies diluted in antibody diluent (Invitrogen), including mouse anti-CK7 (1:200, Abcam), rabbit anti-CK19 (1:200, Abcam), |
